Evidence map›Paper›PMID 35999578›Full record

ArticleGenome medicine2022

ESBL plasmids in Klebsiella pneumoniae: diversity, transmission and contribution to infection burden in the hospital setting.

Jane Hawkey, Kelly L Wyres, Louise M Judd, Taylor Harshegyi, Luke Blakeway, Ryan R Wick, Adam W J Jenney, Kathryn E Holt

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. mSystems · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Comprehensive Analysis ofMicroorganisms · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jane Hawkey *Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia. jane.hawkey@monash.edu.ORCID 0000-0001-9661-5293
Kelly L Wyres *Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Louise M JuddDepartment of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Taylor HarshegyiDepartment of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Luke BlakewayDepartment of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Ryan R WickDepartment of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Adam W J JenneyMicrobiology Unit & Department of Infectious Diseases, The Alfred Hospital, Melbourne, VIC, Australia.
Kathryn E HoltDepartment of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, Australia. kat.holt@lshtm.ac.uk.
Monash University · AULondon School of Hygiene & Tropical Medicine · GBThe Alfred Hospital · AU

Funding

National Health and Medical Research Council 1043822National Health and Medical Research Council APP1176192
6 · The paper itself

Abstract

backgroundResistance to third-generation cephalosporins, often mediated by extended-spectrum beta-lactamases (ESBLs), is a considerable issue in hospital-associated infections as few drugs remain for treatment. ESBL genes are often located on large plasmids that transfer horizontally between strains and species of Enterobacteriaceae and frequently confer resistance to additional drug classes. Whilst plasmid transmission is recognised to occur in the hospital setting, the frequency and impact of plasmid transmission on infection burden, compared to ESBL + strain transmission, is not well understood.

methodsWe sequenced the genomes of clinical and carriage isolates of Klebsiella pneumoniae species complex from a year-long hospital surveillance study to investigate ESBL burden and plasmid transmission in an Australian hospital. Long-term persistence of a key transmitted ESBL + plasmid was investigated via sequencing of ceftriaxone-resistant isolates during 4 years of follow-up, beginning 3 years after the initial study.

resultsWe found 25 distinct ESBL plasmids. We identified one plasmid, which we called Plasmid A, that carried bla

conclusionsHere, we systematically surveyed ESBL strain and plasmid transmission over 1 year in a single hospital network. Whilst ESBL plasmid transmission events were rare in this setting, they had a significant and sustained impact on the burden of ceftriaxone-resistant and multidrug-resistant infections. If onward transmission of Plasmid A-carrying strains could have been prevented, this may have reduced the number of opportunities for Plasmid A to transmit and create novel ESBL + strains, as well as reducing overall ESBL infection burden.

Indexed as

beta-LactamasesKlebsiella pneumoniaeAnti-Bacterial AgentsAustraliaCeftriaxoneHospitalsHumansPlasmidsAnti-Bacterial Agentsbeta-LactamasesCeftriaxoneESBLKlebsiella pneumoniaPlasmidsThird-generation cephalosporin resistance

Identifiers

PMID35999578
PMCPMC9396894
OpenAlexW4292738219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.